Section: INFLAMMATION
AND ALLERGY DRUG DESIGN AND DISCOVERY
Organizing Secretary: Kenji Izuhara
Division of Medical Biochemistry
Department of Biomolecular Sciences, Head of Clinical Laboratory
The Medical School Hospital
Japan
PLENARY LECTURES
|
Inflammation and Allergy Drug Design and Discovery
Kenji Izuhara
Division of Medical Biochemistry, Department of Biomolecular
Sciences, Head of Clinical Laboratory, The Medical School
Hospital, Japan
|
| INVITED LECTURES
|
Development of New Therapeutic Approaches in
Allergy and Lung Disease: The Antisense Strategies
Harald Renz
Department of Clinical Chemistry and Molecular Diagnostic,
University Hospital Giessen and Marburg, Germany
|
| Drug Discovery for Allergic Diseases; Tranilast,
Suplatast and Feature Drugs
Hiroichi Nagai
Gifu Pharmaceutical University, Japan
|
| Differential Production of Connective Tissue-Type
and Mucosal Mast Cells from Human Embryonic Stem Cells
for Anti-Allergy Drug Screening
Kohichiro Tsuji
Division of Cellular Therapy, Institute of Medical Science,
University of Tokyo, Japan
|
| Developing Novel Anti-Inflammatory Therapy
for Asthma/COPD
Yi Wang
Alexion Pharmaceuticals Inc., USA
|
| Assessing the Infection Risks of New Anti-Inflammatory
Therapies
Robert s. Wallis
Associate Professor, UMDNJ-NJMS, Medical Director, PPD,
USA
|
| The Substance P System as a Target in the
Development of Peptidomimetics Acting as Potential Pain
Relievers and as Drugs for Treatment of opioid Addiction
Fred Nyberg
Department of Pharmaceutical Biosciences, Uppsala University,
Sweden
|
| P13Kγ and P13Kδ Partners in Crime in Inflammation?
Rheumatoid Arthritis and Beyond
S.A. Merck Serono
Geneva Research Centre 9, Switzerland
|
|
